Overview


According to FutureWise analysis the market for aortic valve in 2023 is US$ 12.41 billion, and is expected to reach US$ 33.99 billion by 2031 at a CAGR of 13.42%.

The aortic valve holds significant importance within the human heart, acting as a pivotal regulator of blood flow in the cardiovascular system. Positioned between the left ventricle and the aorta, this semilunar valve ensures the efficient distribution of oxygenated blood from the heart to the entire body. The aortic valve opens as the left ventricle contracts, permitting blood to enter the aorta. Conversely, when the ventricle relaxes, the valve closes, preventing reverse flow into the heart.

Maintaining a healthy aortic valve is crucial for optimal cardiac function. However, various conditions can lead to its malfunction. A prevalent concern is aortic stenosis, characterized by a narrowed valve restricting blood flow. This can arise from factors like aging, congenital abnormalities, or the accumulation of calcium on the valve leaflets. Another issue is aortic regurgitation, where the valve fails to seal tightly, allowing blood to leak back into the heart. The choice of treatment for aortic valve disorders depends on their severity and the patient's overall health. Regular monitoring may suffice in mild cases, whereas more severe conditions necessitate medication or surgical intervention. Recent years have witnessed notable progress in aortic valve replacement techniques, with minimally invasive procedures emerging as viable alternatives to conventional open-heart surgery. These breakthroughs have significantly enhanced patient outcomes and shortened recovery periods.

FutureWise Market Research has published a report that provides an insightful analysis of Aortic Valve Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Aortic Valve Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Boston Scientific Corporation
  • JenaValve Technology Inc.
  • Edwards Lifesciences Corporation
  • Thubrikar Aortic Valve Inc.
  • CryoLife Inc.
  • LifeNet Health Inc.
  • Medtronic plc
  • Coroneo Inc.
  • LivaNova PLC
  • Anteris Technologies Ltd.
  • Abbott Laboratories

(Note: The list of the major players will be updated with the latest market scenario and trends)

The global population leads to a higher prevalence of aortic valve disorders. As individuals age, the risk of aortic stenosis and regurgitation increases, driving the demand for aortic valve interventions. Ongoing innovations in medical technology have led to the development of more advanced and minimally invasive procedures for aortic valve replacement. These advancements have improved patient outcomes and reduced recovery times, making treatment options more accessible and practical. Growing awareness of heart health and campaigns promoting regular health check-ups have led to early detection and treatment of aortic valve disorders. This trend is positively impacting the aortic valve market. Cardiovascular diseases, including aortic valve disorders, are a leading cause of morbidity and mortality worldwide. This high prevalence is a significant driver for the aortic valve market.  Supportive policies and initiatives by governments and healthcare organizations, including reimbursement schemes, can incentivize patients to seek treatment for aortic valve conditions, thereby bolstering the market. 

However, aortic valve replacement procedures, incredibly advanced and minimally invasive techniques, can be expensive. This cost can be a significant barrier for individuals with limited, inadequate insurance coverage or financial resources.  Access to advanced medical facilities and specialized cardiac care may be limited in specific regions or countries. This can hinder the adoption of cutting-edge aortic valve interventions.

By Valve Type

  • Tissue/biological
  • Mechanical

By Suture Type

  • Sutured
  • Sutureless

By Procedure

  • Open Surgery
    • Tissue/biological
    • Mechanical
  • Minimally Invasive Surgery (MIS)
    • Transfemoral aortic valve replacement (TF-AVR)
    • Transapical aortic valve replacement (TA-AVR)
    • Others

By End User

  • Hospitals
  • Ambulatory Surgery Centers (ASCs)

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to rise in the prevalence of cardiovascular diseases, robust healthcare infrastructure, the prominent presence of key industry players, and heightened research endeavors in this geographical region. Conversely, the Europe region is poised for substantial expansion in the forecast period due to increasing support from regulatory authorities to control cardiovascular diseases, an upswing in research initiatives, access to extensive untapped markets, a sizable population base, and an escalating demand for high-quality healthcare services.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Aortic Valve Market By Valve Type, By Suture Type, By Procedure, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- Valve Type launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Aortic Valve Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Aortic Valve Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Aortic Valve Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Aortic Valve Market, By Valve Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Tissue/biological
        2. Mechanical

  • 8.   Aortic Valve Market, By Suture Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Sutured
        2. Sutureless

  • 9.   Aortic Valve Market, By Procedure Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Open Surgery
         1.1. Tissue/biological
         1.2. Mechanical
        2. Minimally Invasive Surgery (MIS)
         2.1. Transfemoral aortic valve replacement (TF-AVR)
         2.2. Transapical aortic valve replacement (TA-AVR)
         2.3. Others

  • 10.   Aortic Valve Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospitals
        2. Ambulatory Surgery Centers (ASCs)

  • 11.   North America Aortic Valve Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Aortic Valve Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Aortic Valve Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Aortic Valve Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Boston Scientific Corporation
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. JenaValve Technology Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Edwards Lifesciences Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Thubrikar Aortic Valve Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. CryoLife Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. LifeNet Health Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Medtronic plc
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Coroneo Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. LivaNova PLC
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
          10. Anteris Technologies Ltd..
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Abbott Laboratories
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

Related Market

Transcatheter Aortic Valve Replacement Market

Read More

Aortic Valve Replacement Devices Market

Read More

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11